SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001827506-24-000036
Filing Date
2024-05-13
Accepted
2024-05-13 16:18:31
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q trml-20240331.htm   iXBRL 10-Q 1136322
2 EX-10.1 a03312024exhibit101.htm EX-10.1 17311
3 EX-31.1 a03312024exhibit311.htm EX-31.1 9497
4 EX-31.2 a03312024exhibit312.htm EX-31.2 9844
5 EX-32.1 a03312024exhibit321.htm EX-32.1 7705
  Complete submission text file 0001827506-24-000036.txt   5205822

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trml-20240331.xsd EX-101.SCH 36098
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trml-20240331_cal.xml EX-101.CAL 46144
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trml-20240331_def.xml EX-101.DEF 185914
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trml-20240331_lab.xml EX-101.LAB 433301
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trml-20240331_pre.xml EX-101.PRE 321673
69 EXTRACTED XBRL INSTANCE DOCUMENT trml-20240331_htm.xml XML 561111
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40384 | Film No.: 24939329
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)